FDA Inspection
Merck and CompanyMerck and Company – FDA Inspection, May 2, 2012
Record Details
This FDA Inspection record concerns Merck and Company, with an inspection on May 2, 2012, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Merck and Company
- Inspection Date
- May 2, 2012
- Product Type
- Biologics
View Company Profile
ID · 3dde1f96-ad3c-4c02-939f-cbaa3b742b9c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 784077
- FDA center
- Biologics
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.50Ensuring compliance with plan and protocol
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Merck and Company
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 8, 2009 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Merck and Company
- FDA Inspection 620136 - 2009-10-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.